- Home
- GH vs KBR Comparison
GH vs KBR Comparison
Compare GH & KBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- KBR
- Stock Information
- Founded
- GH 2011
- KBR 1901
- Country
- GH United States
- KBR United States
- Employees
- GH N/A
- KBR N/A
- Industry
- GH Medical Specialities
- KBR Military/Government/Technical
- Sector
- GH Health Care
- KBR Industrials
- Exchange
- GH Nasdaq
- KBR Nasdaq
- Market Cap
- GH 5.5B
- KBR 6.3B
- IPO Year
- GH 2018
- KBR 2006
- Fundamental
- Price
- GH $40.62
- KBR $52.19
- Analyst Decision
- GH Strong Buy
- KBR Strong Buy
- Analyst Count
- GH 21
- KBR 7
- Target Price
- GH $52.81
- KBR $67.57
- AVG Volume (30 Days)
- GH 2.3M
- KBR 1.6M
- Earning Date
- GH 04-30-2025
- KBR 05-06-2025
- Dividend Yield
- GH N/A
- KBR 1.26%
- EPS Growth
- GH N/A
- KBR N/A
- EPS
- GH N/A
- KBR 2.98
- Revenue
- GH $773,996,000.00
- KBR $7,979,000,000.00
- Revenue This Year
- GH $23.05
- KBR $13.82
- Revenue Next Year
- GH $21.40
- KBR $8.49
- P/E Ratio
- GH N/A
- KBR $17.52
- Revenue Growth
- GH 28.20
- KBR 12.84
- 52 Week Low
- GH $20.14
- KBR $43.89
- 52 Week High
- GH $52.92
- KBR $72.60
- Technical
- Relative Strength Index (RSI)
- GH 48.45
- KBR 46.34
- Support Level
- GH $37.73
- KBR $50.30
- Resistance Level
- GH $39.63
- KBR $52.88
- Average True Range (ATR)
- GH 1.60
- KBR 1.20
- MACD
- GH -0.01
- KBR -0.49
- Stochastic Oscillator
- GH 60.00
- KBR 29.17
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About KBR KBR Inc.
KBR, formerly Kellogg Brown & Root, is global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: government solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 34,000 people. The firm generated $7.7 billion in revenue in 2024.